| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 32 |
| 1 | CLADRIBINE | 16 |
| 2 | VEMURAFENIB | 9 |
| 3 | PENTOSTATIN | 7 |
| 4 | BENDAMUSTINE HCL | 6 |
| 5 | DABRAFENIB | 5 |
| 6 | CYCLOPHOSPHAMIDE | 2 |
| 7 | CYCLOPHOSPHAMIDE FOR INJECTION | 2 |
| 8 | CYCLOPHOSPHAMIDE INJECTION, SOLUTION | 2 |
| 9 | CYTARABINE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PENTOSTATIN | 7 | 0.0067 |
| 1 | CLADRIBINE | 16 | 0.0016 |
| 2 | VEMURAFENIB | 9 | 0.0008 |
| 3 | BENDAMUSTINE HCL | 6 | 0.0004 |
| 4 | GLOFITAMAB | 1 | 0.0004 |
| 5 | DABRAFENIB | 5 | 0.0002 |
| 6 | RITUXIMAB | 32 | 0.0001 |
| 7 | BENDAMUSTINE HYDROCHLORIDE | 1 | 0.0001 |
| 8 | PEGFILGRASTIM | 1 | 0.0001 |
| 9 | TRAMETINIB | 2 | 0.0001 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Bispecific CD20-directed CD3 T Cell Engager [EPC] | 1 | 0.0002 |
| 1 | Purine Antimetabolite [EPC] | 16 | 0.0002 |
| 2 | CD20-directed Cytolytic Antibody [EPC] | 32 | 0.0001 |
| 3 | Phenothiazine [EPC] | 1 | 0.0000 |
| 4 | Nucleoside Metabolic Inhibitor [EPC] | 9 | 0.0000 |
| 5 | Epidermal Growth Factor Receptor Antagonist [EPC] | 1 | 0.0000 |
| 6 | Kinase Inhibitor [EPC] | 11 | 0.0000 |
| 7 | BCL-2 Inhibitor [EPC] | 1 | 0.0000 |
| 8 | Serotonin Reuptake Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Herpesvirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |